August 20, 2017 6:14 AM ET

Biotechnology

Company Overview of NAL Pharmaceuticals Ltd.

Company Overview

NAL Pharmaceuticals Ltd. provides drug development and delivery focusing on chronic severe pain, breakthrough pain, arthritic pain, migraine, asthma, post-chemotherapy emesis, smoking cessation, wound healing, and eye care. The company’s drug delivery technologies include Bio-FX, Bio-D3, and Bio-CR. NAL Pharmaceuticals Ltd. is based in Causeway Bay, Hong Kong.

311 Gloucester Road

Windsor House

Room 2109

Causeway Bay,  999077

Hong Kong

Key Executives for NAL Pharmaceuticals Ltd.

NAL Pharmaceuticals Ltd. does not have any Key Executives recorded.

NAL Pharmaceuticals Ltd. Key Developments

NAL Pharmaceuticals Ltd. Presents at BIO-Europe 2015, Nov-02-2015

NAL Pharmaceuticals Ltd. Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NAL Pharmaceuticals Ltd., please visit www.nalpharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.